1. A system for producing synthesis gas comprising CO and H2, the system comprising:
a first gasification reactor comprising a first-reactor oxygen inlet for a first oxygen-containing stream, a first-reactor fuel inlet for a first, carbonaceous stream, and a first-reactor outlet for raw synthesis gas produced in the first gasification reactor;
a second gasification reactor comprising a second-reactor oxygen inlet for a second oxygen-containing stream, a second-reactor fuel inlet for a second carbonaceous stream, and a second-reactor outlet for raw synthesis gas produced in the second gasification reactor;
an oxygen source of an oxygen containing stream; and
a distributor for fluidly connecting the oxygen source to the first-reactor oxygen inlet and to the second-reactor oxygen inlet, the distributor being arranged to selectively connect the oxygen source to the first or second gasification reactor.
2. The system of claim 1, wherein the oxygen-containing stream comprises greater than 50 vol. % O2.
3. The system of claim 1, wherein the oxygen-containing stream comprises greater than 99 vol. % O2.
4. The system of claim 1, wherein the first carbonaceous stream is selected from the group consisting of a particulate and a liquid stream and the second carbonaceous stream is selected from a group consisting of a gaseous and liquid stream and a mixture thereof.
5. The system of claim 1, wherein the first carbonaceous stream is a particulate stream.
6. The system of claim 5, wherein the second carbonaceous stream is a gaseous stream.
7. The system of claim 1, wherein the second carbonaceous stream is a gaseous stream.
8. The system of claim 7, wherein the first carbonaceous stream is a liquid stream.
9. The system of claim 1, wherein the oxygen source comprises an air separation unit having a maximum oxygen capacity of less than 80% of the sum of the oxygen requirements for the first and the second gasification reactors.
10. The system of claim 9, wherein the maximum oxygen capacity of the air separation unit is less than 65% of the sum of the oxygen requirements for the first and the second gasification reactors.
11. The system of claim 1, further comprising a second first gasification reactor.
12. The system of claim 1, further comprising a shift converter being connected to the first-reactor outlet and the second-reactor outlet, in which shift converter at least a part of the CO in the synthesis gas may be reacted to produce CO2 and H2.
13. A method of producing synthesis gas comprising CO and H2, from a carbonaceous stream using an oxygen-containing stream, the method comprising the steps of:
(a) injecting a first carbonaceous stream and a first oxygen containing stream into a first gasification reactor, the first oxygen-containing stream originating from a source of oxygen;
(b) at least partially oxidising the first carbonaceous stream in the first gasification reactor, thereby obtaining a first raw synthesis gas;
(c) removing the first raw synthesis gas obtained in step (b) from the first gasification reactor;
(d) injecting a second carbonaceous stream and a second oxygen-containing stream into a second gasification reactor, and wherein the second oxygen containing stream originates from the source of oxygen used in step (a);
(e) at least partially oxidising the second carbonaceous stream in the second gasification reactor, thereby obtaining a second raw synthesis gas; and
(f) removing the second raw synthesis gas obtained in step (e) from the second gasification reactor;
wherein the first and second gasification reactors are used alternately.
14. The method of claim 13, wherein the oxygen containing stream comprises greater than 50 vol. % O2.
15. The method of claim 13, wherein the oxygen containing stream comprises greater than 99 vol. % O2.
16. The method of claim 13, wherein the first carbonaceous stream is selected from a group consisting of a particulate and a liquid stream and the second carbonaceous stream is selected from a group consisting of a gaseous and liquid stream and a mixture thereof.
17. The method of claim 13, wherein the first carbonaceous stream is a particulate stream.
18. The method of claim 17, wherein the second carbonaceous stream is a gaseous stream.
19. The method of claim 13, wherein the second carbonaceous stream is a gaseous stream.
20. The method of claim 19, wherein the first carbonaceous stream is a liquid stream.
21. The method of claim 13, further comprising the steps of:
(g) transporting at least one of the first synthesis gas removed in step (c) and the second synthesis gas removed in step (f) to a shift converter; and
(h) reacting at least a part of the CO comprised in the at least one of the first and second synthesis gas transported in step (g) to produce CO2 and H2.
22. A method using a spare gasification reactor in a process to generate power from a source of petroleum coke in one or more parallel operated gasification reactors, which spare reactor is capable of preparing a spare synthesis gas mixture comprising carbon monoxide and hydrogen by partial oxidation of at least one of a vacuum residue and natural gas, using up to a maximum first volume of oxygen per hour as obtained from an air separation unit, and wherein power is generated from the petroleum coke by
(aa) partial oxidation of the petroleum coke using up to a maximum second volume of oxygen per hour as obtained from the air separation unit, to yield a synthesis gas mixture,
(bb) using at least one of the synthesis gas mixture as obtained from step (aa) and the optional spare synthesis gas mixture to generate power wherein a maximum capacity of the air separation unit is less than the sum of the maximum first and second oxygen volumes per hour.
23. The method of claim 22, further comprising a step of isolating carbon dioxide prior to the power generation.
24. The method of claim 23, wherein the carbon dioxide is isolated in a gas turbine.
25. The method of claim 22 carried out in the system of claim 1.
26. A process to prepare hydrogen from a source of petroleum coke in one or more parallel operated gasification reactors employing a spare gasification reactor, which spare reactor is capable of preparing an optional spare synthesis gas mixture comprising carbon monoxide and hydrogen, by partial oxidation of at least one of a vacuum residue and natural gas, using up to a maximum first volume of oxygen per hour as obtained from an air separation unit, and wherein hydrogen is prepared from the petroleum coke by
(aa1) partial oxidation of the petroleum coke using up to a maximum second volume of oxygen per hour as obtained from the air separation unit to yield a synthesis gas mixture,
(bb1) subjecting at least one of the synthesis gas mixture as obtained from step (aa1) and the optional spare synthesis gas mixture to a water gas shift step to obtain shifted gas,
(cc1) subjecting the shifted gas to a gas separation step to obtain a hydrogen enriched mixture,
wherein the maximum capacity of the air separation unit is less than the sum of the maximum first and second oxygen volumes per hour.
27. The process of claim 26, wherein the gas separation step comprises a pressure swing absorbing process.
28. The process of claim 26 carried out in the system of claim 1.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method of ameliorating blood lipid levels, selected from the group consisting of total cholesterol levels, lipid peroxide levels, free fatty acid levels and triglyceride levels, said method comprising administering, in combination, to a warm-blooded animal in need thereof, in amounts to form a synergistically effective mixture for ameliorating said blood lipid levels, atorvastatin and agent selected from the group consisting of a riboflavin derivative, a tocopherol derivative, an ascorbic acid derivative, pantethine and taurine.
2. A method according to claim 1 wherein said atorvastatin and said agent selected from the group consisting of said riboflavin derivative, said tocopherol derivative, said ascorbic acid derivative, said pantethine and said taurine, are administered in the form of a combination pharmaceutical composition.
3. A method according to claim 1 wherein said atorvastatin and said agent selected from the group consisting of said riboflavin derivative, said tocopherol derivative, said ascorbic acid derivative, said pantethine and said taurine are administered separately and simultaneously.
4. A method according to claim 1 wherein said atorvastatin and said agent selected from the group consisting of said riboflavin derivative, said tocopherol derivative, said ascorbic acid derivative, said pantethine and said taurine, are administered separately and non-simultaneously.
5. A method according to claim 1 wherein the ingredient is said riboflavin derivative which is selected from the group consisting of riboflavin, flavin-adenine dinucleotide and flavin-adenine dinucleotide sodium salt.
6. A method according to claim 1 wherein the ingredient is said riboflavin derivative which is riboflavin sodium phosphate.
7. A method according to claim 1 wherein the ingredient is said riboflavin derivative which is riboflavin butyrate.
8. A method according to claim 1 wherein the ingredient is said tocopherol derivative which is selected from the group consisting of dl-\u03b1-tocopherol succinate, dl-\u03b1-tocopherol calcium succinate, dl-\u03b1-tocopherol acetate, d-\u03b1-tocopherol and dl-\u03b1-tocopherol.
9. A method according to claim 1 wherein the ingredient is said tocopherol derivative which is d-\u03b1-tocopherol succinate.
10. A method according to claim 1 wherein the ingredient is said tocopherol derivative which is d-\u03b1-tocopherol acetate.
11. A method according to claim 1 wherein the ingredient is said ascorbic acid derivative which is selected from the group consisting of sodium ascorbate and calcium ascorbate.
12. A method according to claim 1 wherein the ingredient is said ascorbic acid derivative which is ascorbic acid.
13. A method of ameliorating blood lipid levels according to claim 1, said method comprising administering, in combination, to a warm-blooded animal in need thereof, in amounts to form a synergistically effective mixture for ameliorating said blood lipid levels, atorvastatin and riboflavin succinate.
14. A method according to claim 13 wherein said atorvastatin and said riboflavin succinate are administered in the form of a combination pharmaceutical composition.
15. A method according to claim 13 wherein said atorvastatin and said riboflavin succinate are administered separately and simultaneously.
16. A method according to claim 13 wherein said atorvastatin and said riboflavin succinate are administered separately and non-simultaneously.
17. A method of ameliorating blood lipid levels according to claim 1, said method comprising administering, in combination, to a warm-blooded animal in need thereof, in amounts to form a synergistically effective mixture for ameliorating said blood lipid levels, atorvastatin and ascorbic acid.
18. A method according to claim 17 wherein said atorvastatin and said ascorbic acid are administered in the form of a combination pharmaceutical composition.
19. A method according to claim 17 wherein said atorvastatin and said ascorbic acid are administered separately and simultaneously.
20. A method according to claim 17 wherein said atorvastatin and said ascorbic acid are administered separately and non-simultaneously.
21. A method of ameliorating blood lipid levels according to claim 1, said method comprising administering, in combination, to a warm-blooded animal in need thereof, in amounts to form a synergistically effective mixture for ameliorating said blood lipid levels, atorvastatin and d-\u03b1-tocopherol acetate.
22. A method according to claim 21 wherein said atorvastatin and said d-\u03b1-tocopherol acetate are administered in the form of a combination pharmaceutical composition.
23. A method according to claim 21 wherein said atorvastatin and said d-\u03b1-tocopherol acetate are administered separately and simultaneously.
24. A method according to claim 21 wherein said atorvastatin and said d-\u03b1-tocopherol acetate are administered separately and non-simultaneously.
25. A method of ameliorating blood lipid levels according to claim 1, said method comprising administering, in combination, to a warm-blooded animal in need thereof, in amounts to form a synergistically effective mixture for ameliorating said blood lipid levels, atorvastatin and pantethine.
26. A method according to claim 25 wherein said atorvastatin and said pantethine are administered in the form of a combination pharmaceutical composition.
27. A method according to claim 25 wherein said atorvastatin and said pantethine are administered separately and simultaneously.
28. A method according to claim 25 wherein said atorvastatin and said pantethine are administered separately and non-simultaneously.
29. A method of ameliorating blood lipid levels according to claim 1, said method comprising administering, in combination, to a warm-blooded animal in need thereof, in amounts to form a synergistically effective mixture for ameliorating said blood lipid levels, atorvastatin and taurine.
30. A method according to claim 29 wherein said atorvastatin and said taurine are administered in the form of a combination pharmaceutical composition.
31. A method according to claim 29 wherein said atorvastatin and said taurine are administered separately and simultaneously.
32. A method according to claim 29 wherein said atorvastatin and said taurine are administered separately and non-simultaneously.
33. A method according to claim 1 wherein the warm-blooded animal is a human.